🔗 Permalink

Inventor profile of:

Stefan Steidl

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2024-12-26

Top Assignees for applications by Stefan Steidl

The entities that hold a legal rights for patent applications filed by inventor Steidl Stefan:

MORPHOSYS AG 4 Martinsried, Germany
MORPHOSYS AG 3 Planegg-Martinsried, Germany
MorphoSys AG 2 Martinsried/Planegg, Germany
MorphoSys AG 2 Planegg, Germany
The University of Melbourne 1 Carlton, Australia
THE UNIVERSITY OF MELBOURNE 1 PARKVILLE, Australia
University of Melbourne 1 Victoria, Australia
Morpho Sys AG 1 Planeggi, Germany

Recent patent applications by Steidl Stefan

Stefan Steidl from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-12-26

US20240424012A1

Human necessities

COMBINATIONS AND USES THEREOF

#2 | 2024-11-07

US20240366756A1

Human necessities

COMBINATIONS AND USES THEREOF

#3 | 2024-07-11

US20240228654A9

Chemistry; metallurgy

ANTI-CD38 ANTIBODIES FOR USE IN THE TREATMENT OF ANTIBODY-MEDIATED TRANSPLANT REJECTION

#4 | 2024-04-25

US20240132618A1

Chemistry; metallurgy

ANTI-CD38 ANTIBODIES FOR USE IN THE TREATMENT OF ANTIBODY-MEDIATED TRANSPLANT REJECTION

#5 | 2024-04-04

US20240109977A1

Chemistry; metallurgy

ANTI-CD38 ANTIBODIES AND THEIR USES

#6 | 2022-05-12

US20220144965A1

Chemistry; metallurgy

ANTI-CD38 ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF AUTOANTIBODY-MEDIATED AUTOIMMUNE DISEASE

#7 | 2021-11-11

US20210347879A1

Chemistry; metallurgy

ANTI-GM-CSF ANTIBODIES

#8 | 2020-11-12

US20200353077A1

Human necessities

COMBINATIONS AND USES THEREOF

#9 | 2020-11-12

US20200352975A1

Human necessities

COMBINATIONS AND USES THEREOF

#10 | 2020-01-23

US20200024340A1

Chemistry; metallurgy

Nucleic acid encoding anti-GM-CSF antibodies

#11 | 2018-08-23

US20180237531A1

Chemistry; metallurgy

METHOD FOR THE TREATMENT OF PAIN AND OSTEOARTHRITIS WITH C-FMS ANTAGONISTS

#12 | 2018-08-16

US20180230208A1

Chemistry; metallurgy

Treatment for rheumatoid arthritis

#13 | 2017-08-03

US20170218061A1

Chemistry; metallurgy

Methods of treatment using anti-GM-CSF antibodies

#14 | 2016-06-30

US20160185867A1

Chemistry; metallurgy

Method for treatment of osteoarthritis with C-Fms antagonists

#15 | 2014-09-11

US20140255427A1

Human necessities

COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARD

#16 | 2014-08-14

US20140227277A1

Human necessities

Combination therapy with an anti-CD19 antibody and a purine analog

#17 | 2014-07-24

US20140205608A1

Chemistry; metallurgy

Use of M-CSF antibodies in the treatment of osteoarthritis or pain

#18 | 2011-05-12

US20110110944A1

Chemistry; metallurgy

ANTI-ALK1 ANTIBODIES AND USES THEREOF

#19 | 2011-02-24

US20110045000A1

Chemistry; metallurgy

Anti-GM-CSF antibodies

#20 | 2010-11-18

US20100291078A1

Chemistry; metallurgy

Proteinaceous binding molecules comprising purification tags or inert variable domains

#21 | 2009-02-26

US20090053213A1

Chemistry; metallurgy

Anti-GM-CSF antibodies and uses therefor

InventorID:

846011 ⎘